ChromaDex Corporation (CDXC)

ChromaDex Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	83.17	83.57	72.05	67.45	59.26	46.29
Revenue Growth (YoY)	7.52%	15.99%	6.82%	13.82%	28.01%	46.69%
Cost of Revenue	32.45	32.79	29.25	25.96	23.98	20.52
Gross Profit	50.72	50.78	42.8	41.49	35.27	25.77
Selling, General & Admin	49.22	51.42	56.6	64.73	51.71	52.52
Research & Development	5.86	4.96	4.83	3.83	3.42	4.42
Other Operating Expenses	0	0	0	0	0	0.13
Operating Expenses	55.08	56.38	61.43	68.56	55.13	57.07
Operating Income	-4.36	-5.6	-18.63	-27.07	-19.85	-31.3
Interest Expense / Income	0.07	0	0	0.06	0.07	0.85
Other Expense / Income	-0.9	-0.66	-2.09	-	-	-
Pretax Income	-3.53	-4.94	-16.54	-27.13	-19.93	-32.15
Net Income	-3.53	-4.94	-16.54	-27.13	-19.93	-32.15
Shares Outstanding (Basic)	75	75	70	67	61	57
Shares Outstanding (Diluted)	75	75	70	67	61	57
Shares Change	0.58%	7.54%	3.79%	10.02%	7.03%	3.73%
EPS (Basic)	-0.05	-0.07	-0.24	-0.40	-0.33	-0.56
EPS (Diluted)	-0.05	-0.07	-0.24	-0.40	-0.33	-0.56
Free Cash Flow	4.53	6.97	-15.43	-24.57	-10.72	-21.18
Free Cash Flow Per Share	0.06	0.09	-0.22	-0.37	-0.18	-0.37
Gross Margin	60.98%	60.76%	59.40%	61.51%	59.53%	55.67%
Operating Margin	-5.24%	-6.70%	-25.85%	-40.14%	-33.50%	-67.62%
Profit Margin	-4.24%	-5.91%	-22.96%	-40.22%	-33.62%	-69.45%
Free Cash Flow Margin	5.44%	8.35%	-21.42%	-36.43%	-18.10%	-45.76%
EBITDA	-1.81	-3.23	-14.66	-25.45	-18.34	-29.78
EBITDA Margin	-2.17%	-3.87%	-20.34%	-37.73%	-30.95%	-64.33%
Depreciation & Amortization	1.66	1.71	1.88	1.63	1.51	1.52
EBIT	-3.46	-4.94	-16.54	-27.07	-19.85	-31.3
EBIT Margin	-4.16%	-5.91%	-22.96%	-40.14%	-33.50%	-67.62%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).